Published
Type 2 Diabetes Mellitus and Metabolic Syndrome
Published in June 2016 Issue 3 (Vol. 6, Issue 3, 2016)

Keywords
Abstract
Metabolic syndrome is a constellation of interrelated cardio-metabolic risk factors that include Central Obesity, Hyperglycemia, Hypertension and Dyslipidemia. It has been estimated that about 1 in 5 (20.4%) adults in the U.S. have high blood pressure, it is very crucial to evaluate the serious health problems, level of awareness and knowledge about conditions relevant to metabolic disorders. Metabolic syndrome is caused not by genetic defects alone; in most cases, genetic factors predispose a person to a disease, while lifestyle factors determine whether (and when) the disease will develop. Several studies have demonstrated clearly the importance of dietary factors and physical activity level in the development of the metabolic syndrome. Given the same dietary and lifestyle factors, some individuals may be more prone to type 2 diabetes than others because of different genetic backgrounds. At a public health level, more attention must be given to modification of lifestyles of the general public to reduce risk of obesity and T2DM and to increase physical activity. At a clinical level, individual patients with increased metabolic risk need to be identified so that their multiple risk factors can be reduced. Considering the long asymptomatic period often preceding the manifestation of T2DM and CVD, early diagnosis could enable earlier targeted interventions such as implementation of healthy lifestyle changes in nutritional behavior and exercise or pharmacotherapy, thus reducing disease development. A deeper understanding of the underlying gene- interactions In terms of both public health and for individuals and genetic subgroups is therefor needed.
Authors (2)
Dhanya Hariharan
View all publications →Shibina Shan
View all publications →Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Article Information
Published in:
June 2016 Issue 3 (Vol. 6, Issue 3, 2016)- Article ID:
- AJPTR63003
- Paper ID:
- AJPTR-01-002796
- Published Date:
- 2016-06-01
Article Impact
Views:5,973
Downloads:1,252
How to Cite
Hariharan & Shan (2016). Type 2 Diabetes Mellitus and Metabolic Syndrome. American Journal of PharmTech Research, 6(3), xx-xx. https://ajptr.scholarjms.com/articles/1761
Article Actions
More from this Issue
Management of co- morbid depression in Diabetic patients : A Review
Aswathy Vijayan, Roshin E...Read more →
Approaches and advances in transdermal delivery of insulin -A Review
Jigyasa vindru, Aravind R...Read more →
Buccal Route As A Novel Delivery Route
Ankita S. Dhumal, Sudha R...Read more →
More by These Authors
Efficacy of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Muscle Relaxants and Neurotropic Drugs in Patients with Low Back Pain
2015 • Vol. 5, Issue 1
Read more →